← back to search

Bo Shen

Zhejiang University · CN
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, Ferroptosis and cancer prognosis, and Lung Cancer Research Studies.
h-index
18
citations
1,191
works
63
NIH funding
primary concept
email

Recent publications

A real‐world observation on thrombopoietic agents for patients with cancer treatment–induced thrombocytopenia in China: A multicenter, cross‐sectional study
Cancer 2024cited by 13position: middledoi
The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective study
Cancer Medicine 2024cited by 5position: lastdoi
Gastric cancer mesenchymal stem cells via the CXCR2/HK2/PD-L1 pathway mediate immunosuppression
Gastric Cancer 2023cited by 39position: middledoi
Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer
Cellular Signalling 2023cited by 23position: middledoi
Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective study
BMC Cancer 2023cited by 14position: lastdoi
Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial
Investigational New Drugs 2023cited by 3position: lastdoi
Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma
Frontiers in Immunology 2022cited by 48position: lastdoi
Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors
Frontiers in Immunology 2022cited by 18position: middledoi
Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells
Frontiers in Immunology 2022cited by 16position: middledoi
Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer
Frontiers in Immunology 2021cited by 50position: lastdoi
Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia
Gastric Cancer 2021cited by 46position: middledoi
Gastric cancer mesenchymal stem cells inhibitnatural killer cell function by up-regulating FBP1
Central European Journal of Immunology 2021cited by 20position: middledoi
MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF
Cell Death and Differentiation 2021cited by 19position: middledoi
TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma
International Journal of Biological Sciences 2020cited by 37position: lastdoi
TFAP2A Induced KRT16 as an Oncogene in Lung Adenocarcinoma via EMT
International Journal of Biological Sciences 2019cited by 83position: lastdoi
Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis
Cell Death and Disease 2018cited by 150position: middledoi
Gastric cancer tissue-derived mesenchymal stem cells impact peripheral blood mononuclear cells via disruption of Treg/Th17 balance to promote gastric cancer progression
Experimental Cell Research 2017cited by 58position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wei Zhu · Beijing Information Science & Technology University8 papers (2017–2023)Yuanyuan Zhao · Shanxi Medical University6 papers (2017–2023)Shaodi Wen · Nanjing Medical University5 papers (2021–2024)Deqiang Wang · Guangzhou University of Chinese Medicine4 papers (2021–2023)Xiaoyue Du · Zhejiang University4 papers (2021–2024)Miaolin Zhu · Jiangsu University4 papers (2018–2024)Jingwei Xia · Nanjing Medical University4 papers (2021–2024)Wei Zhu · Jiangsu University3 papers (2021–2023)Qianqian Wang · Fudan University3 papers (2018–2023)Banzhou Pan · Nanjing Medical University3 papers (2021–2023)Wenrong Xu · Jiangsu University3 papers (2017–2023)Chao‐Yuan Huang · Hebei Medical University3 papers (2021–2023)Xin Wang · Fujian Medical University3 papers (2021–2023)Xiaoqin Li · Jiangsu University2 papers (2021–2022)Jifeng Feng · Zhejiang Cancer Hospital2 papers (2023–2023)Xiangdong Zhao · Hebei General Hospital2 papers (2017–2018)Li Sun · Jiangsu University2 papers (2017–2018)Wu Yuan · Guangxi Medical University2 papers (2019–2020)Qiuzhi Gao · Jiangsu University2 papers (2022–2023)Yuzhong Chen · Nanjing Medical University2 papers (2021–2022)